Author: Devyn Osborne

Anakinra, added to standard care, did not improve days free from myocarditis complications in patients with acute myocarditis, the ARAMIS trial found.

Inorganic nitrate reduced contrast-induced nephropathy in patients at risk for renal injury undergoing coronary angiography for acute coronary syndrome.

In patients with acute coronary syndrome at high bleeding and ischemic risk, clopidogrel monotherapy after 9 to 12 months of DAPT reduced bleeding risk.

Switching frail patients with atrial fibrillation from a vitamin K antagonist to a novel oral anticoagulant significantly increased bleeding risk.

A simple diagnostic strategy increased new cardiovascular disease diagnoses in patients with COPD or type 2 diabetes, urging its implementation in primary care.

Transfer to a specialized cardiac arrest center did not improve survival or neurologic outcomes in patients with resuscitated non-hospital cardiac arrest.

Adding aspirin to dual antiplatelet therapy after percutaneous coronary intervention did not increase bleeding risk and may protect against coronary events.

Intravenous ferric carboxymaltose shows long-term safety and clinical benefits in patients with HFrEF and iron deficiency, the HEART-FID study found.

Acoramidis provides clinical and functional benefits in transthyretin amyloid cardiomyopathy, significantly reducing all-cause and cardiovascular mortality.